Cargando…

Biofunctionalized Decellularized Tissue-Engineered Heart Valve with Mesoporous Silica Nanoparticles for Controlled Release of VEGF and RunX2-siRNA against Calcification

The goal of tissue-engineered heart valves (TEHV) is to replace normal heart valves and overcome the shortcomings of heart valve replacement commonly used in clinical practice. However, calcification of TEHV is the major bottleneck to break for both clinical workers and researchers. Endothelializati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Wenpeng, Zhu, Xiaowei, Liu, Jichun, Zhou, Jianliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376836/ https://www.ncbi.nlm.nih.gov/pubmed/37508886 http://dx.doi.org/10.3390/bioengineering10070859

Ejemplares similares

Biofunctionalization of decellularized porcine aortic valve with OPG-loaded PCL nanoparticles for anti-calcification
por: Li, Yang, et al.
Publicado: (2019)

Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics
por: Shen, Jianliang, et al.
Publicado: (2014)

Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
por: Xie, Xiaowei, et al.
Publicado: (2023)

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018)

High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery
por: Ultimo, Amelia, et al.
Publicado: (2023)

Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy
por: Chen, Yijie, et al.
Publicado: (2015)

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang, Dandan, et al.
Publicado: (2017)

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery
por: Ngamcherdtrakul, Worapol, et al.
Publicado: (2018)

Mesoporous silica-coated silver nanoparticles as ciprofloxacin/siRNA carriers for accelerated infected wound healing
por: Liu, Qiqi, et al.
Publicado: (2022)

Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer
por: Darvishi, Behrad, et al.
Publicado: (2017)

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
por: Zhuang, Jialang, et al.
Publicado: (2021)

siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells
por: Heidari, Razieh, et al.
Publicado: (2021)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Overcoming the non-kinetic activity of EGFR1 using multi-functionalized mesoporous silica nanocarrier for in vitro delivery of siRNA
por: Parnian, Javad, et al.
Publicado: (2022)

Angiogenic Potential of VEGF Mimetic Peptides for the Biofunctionalization of Collagen/Hydroxyapatite Composites
por: Wang, Suya, et al.
Publicado: (2021)

Inhibition of retinal neovascularization by siRNA targeting VEGF(165)
por: Xia, Xiao-bo, et al.
Publicado: (2008)

Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery
por: Prabhakar, Neeraj, et al.
Publicado: (2016)

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]
Publicado: (2022)

Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy
por: Shahidi, Maryamsadat, et al.
Publicado: (2022)

Amphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells
por: Osipova, Olga, et al.
Publicado: (2020)

Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA
por: Fischer, Thorben, et al.
Publicado: (2021)

Role of Runx2 in Calcific Aortic Valve Disease in Mouse Models
por: Dharmarajan, Subramanian, et al.
Publicado: (2021)

Redox-Sensitive Gelatin/Silica-Aptamer Nanogels for Targeted siRNA Delivery
por: Zhao, Xueqin, et al.
Publicado: (2019)

VEGF(121)-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
por: Goel, Shreya, et al.
Publicado: (2014)

Local application of Usag-1 siRNA can promote tooth regeneration in Runx2-deficient mice
por: Mishima, Sayaka, et al.
Publicado: (2021)

Dendritic Mesoporous Organosilica Nanoparticles with Photosensitizers for Cell Imaging, siRNA Delivery and Protein Loading
por: Omar, Haneen, et al.
Publicado: (2023)

Chitosan/siCkip-1 biofunctionalized titanium implant for improved osseointegration in the osteoporotic condition
por: Zhang, Li, et al.
Publicado: (2015)

Treatment of keloids through Runx2 siRNA-induced inhibition of the PI3K/AKT signaling pathway
por: Lv, Wenchang, et al.
Publicado: (2021)

Design, synthesis and evaluation of VEGF-siRNA/CRS as a novel vector for gene delivery
por: Zhao, Wen, et al.
Publicado: (2016)

VEGF Overexpression Significantly Increases Nanoparticle-Mediated siRNA Delivery and Target-Gene Downregulation
por: Tan, Shanshan, et al.
Publicado: (2022)

The Effect of Heparin-VEGF Multilayer on the Biocompatibility of Decellularized Aortic Valve with Platelet and Endothelial Progenitor Cells
por: Ye, Xiaofeng, et al.
Publicado: (2013)

Biosafety of Mesoporous Silica Nanoparticles
por: Rascol, Estelle, et al.
Publicado: (2018)

Mesoporous Silica Nanoparticles in Bioimaging
por: Yuan, Daohe, et al.
Publicado: (2020)

Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer
por: Zhao, Zhen, et al.
Publicado: (2019)

Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA
por: Li, Jin-Ming, et al.
Publicado: (2013)

Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us?
por: Badria, Adel F., et al.
Publicado: (2020)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Biofunctionalized Scaffold in Bone Tissue Repair
por: Diomede, Francesca, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3k54eid2qtp1m9ck3pe64rttj1